HUM Humana Inc.
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.…
Industry Peers
Healthcare PlansKey Statistics
About Humana (NYSE: HUM)
›
Humana (NYSE: HUM) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Healthcare Plans industry, part of the Healthcare sector, and reports about 67,060 employees.
The shares were at 380.10 USD on 19 November 2026, up 61.9% over 52 weeks. Its 52-week range is 163.11 USD to 462.87 USD: the price is 17.9% below the high and 133.0% above the low.
At a market capitalisation of 45.64B USD, it trades at 37.1 times trailing earnings and 20.6 times forward earnings. The median trailing P/E of its 9 largest Healthcare Plans peers is 18.9, a premium of 97% for HUM. It pays a dividend yielding 0.92% (it pays out 35% of its earnings), against a median of 2.42% among the dividend payers in that peer group.
Humana reports return on equity of 6.7%, an operating margin of 1.8% and revenue up 26.1% year over year.
It holds more cash than debt, a net cash position of 11.73B USD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 24 analysts cover the stock, with an average rating of Buy; their mean price target of 508.54 USD is 33.8% above the current price. The next earnings report is expected on 10 February 2027.